250+ investors that invest in your industry and stage
Get 250+ investors tailored to your startup
  • Invest in your industry and stage
  • Emails & contact info included
  • Excel and CSV export
  • Automatically
Trusted by 3,000+ startups

Top 50 Medical Startup Investors in Oceania in July 2025

A list of 50 angel investors and VC (Venture Capital) funds that invest in Medical startups based in Oceania. We rank investors based on the number of investments they made in Medical companies from Oceania. We update this investor list every month.

Top 50 Medical Startup Investors in Oceania in July 2025

Investor Medical Oceania investments
Brandon Capital 12
Artesian VC 8
Medical Research Commercialisation Fund (MRCF) 7
Uniseed 6
Uniseed Ventures 5
Stoic VC 4
Main Sequence Ventures 4
Giant Leap Fund 3
Icehouse Ventures 3
Right Click Capital 3
IP Group 3
Transition Level Investments 3
Regal Funds Management 2
Pacific Channel 2
Matū Group 2
Hostplus 2
Australian Medical Angels 2
Tyson & Blake 2
Carthona Capital 2
Horizons Ventures 2
Sydney Angels 2
Clinton Capital Partners 2
Enterprise Angels 2
Fund WA 2
EVP 2
Starfish Ventures 2
Purpose Ventures 2
Jolimont Global Mining Systems 2
Blackbird Ventures 2
Folklore Ventures 2
Sante Ventures 2
Kurt Alexander 2
Stephen Baxter 1
Mass Medical Angels 1
HESTA 1
New Zealand Venture Investment Fund 1
AustralianSuper 1
Melbourne Angels 1
GD1 1
Watermark Funds Management 1
Auckland UniServices 1
Side Stage Ventures 1
Investible 1
Hillfarrance Venture Capital 1
CSIRO 1
Cure Kids Ventures 1
New Zealand Growth Capital Partners 1
Novartis Venture Fund 1
Tin Alley Ventures 1
Novaquest Capital Management 1
Find investors that fund startups like yours. Automatically.
Our algorithm will find investors that invest in your industry, stage, and geography.
Investor list
Brandon Capital VC Fund · Melbourne, Victoria, Australia
Brandon Capital invests in the most promising biomedical opportunities that have the potential to improve the lives of patients.
Show more
Investment focus
  • Biotechnology, Health Care, Medical
  • Series A, Seed, Series B
  • Australia, United States, United Kingdom
Portfolio highlights
  • CatalYm — Catalym develops antibodies against a placental factor which is overexpressed by various tumour types.
  • AdvanCell — AdvanCell is a vertically integrated, clinical-stage radiopharmaceutical company developing an innovative pipeline of targeted alpha therapies.
  • Myricx Bio — Myricx Pharma is a small molecule drug discovery company engaged in developing novel proprietary inhibitors of human N-myristoyltransferases (NMT), with a primary focus in oncology but also exploring potential applications across other diseases.
Artesian VC VC Fund · Melbourne, Victoria, Australia · 7 investments in the past 12 months
Artesian Capital Management is an alternative investments management company, which was spun out of ANZ Banking Group's capital markets business in 2004, with backing from ANZ Private Equity. Artesian's founding partners, purchased ANZ's stake in 2005. The company has subsequently been fully owned by partners and staff. Since 2004,Artesian has managed specialised funds focused on credit arbitrage and relative-value strategies across global financial markets. In 2008, while continuing to manage credit relative value investment strategies from its New York, London and Singapore offices, Artesian began to make principal investments in seed/early-stage ventures from its offices in Sydney, Melbourne and Shanghai. In 2011, Artesian launched the first of its early stage venture capital funds and now manages AUD +255m. Artesian's VC strategy is to partner with best of breed accelerators, incubators, angel groups and university programs. In 2017, Artesian launched its China VC Fund with a USD 50m cornerstone investment industry super fund Hostplus. Artesian will soon launch a Southeast Asia VC Fund.
Show more
Investment focus
  • Software, Artificial Intelligence, Health Care
  • Seed, Pre-Seed, Series A
  • Australia, United States, Hong Kong
Portfolio highlights
  • Voltavate — Voltavate is dedicated to driving innovation in battery technology to support the global transition towards sustainable energy solutions.
  • Strong Room AI — Software that enables high-strength care through streamlined workflows, continuous analytics, surfaced insights and safeguarded data.
  • SAMA Fertility — SAMA Fertility is a virtual fertility clinic that offers fertility care and treatments, including preservation and evaluation services.
Medical Research Commercialisation Fund (MRCF) VC Fund · Melbourne, Victoria, Australia
Medical Research Commercialisation Fund (MRCF) provides dedicated, investment funding to support the commercialisation of early-stage medical research discoveries that originate from its member institutes. The collaborative nature of the MRCF seeks to foster best practice in the commercialisation of medical innovations.
Show more
Investment focus
  • Biotechnology, Health Care, Medical
  • Series A, Seed, Series B
  • Australia, United States, United Kingdom
Portfolio highlights
  • Glyscend Therapeutics — Glyscend develops a revolutionary approach to treating type 2 diabetes. The company began with the insight that bariatric surgery can lead to the immediate remission of the disease, and has since been engaged in the development of a non-invasive approach which will act on the same mechanism as surgery but fit within the current care pathway. Thecompany's technology is an orally ingestible intestinal coating that prevents the stimulation of duodenal mucosa and inhibits key neurohormonal pathways in the proximal gut. Glyscend is devoted to providing patients with an effective strategy to keep glucose levels under control and eliminate potential side effects like weight gain and hypoglycemia. Meanwhile, the company aims to provide endocrinologists and primary care physicians with the innovative tools they need to treat the disease instead of merely managing it. It was founded in 2014 by co-founders Ashish Nimgaonkar, Michael Parlato, and Pratik Patel.
  • Currus Biologics — Currus Biologics is a biotechnology company that develop CAR-T cell therapies for the treatment of solid tumour cancers.
  • Azura Ophthalmics — Azura Ophthalmics is a clinical-stage company that develops an innovative portfolio of compounds to advance treatments for MGD, the leading cause of DED. By targeting the root cause of MGD, Azura brings the promise of improved health and well-being to millions of people worldwide who suffer from MGD and other ocular surface diseases where treatmentoptions are currently lacking. Azura is underpinned by an experienced management team with an established track record of successfully developing and commercializing novel treatments for ocular surface diseases. The company headquartered in Tel Aviv-Yafo, Israel with operations in Australia and the U.S.
Uniseed VC Fund · Brisbane, Queensland, Australia · 2 investments in the past 12 months
Uniseed was established in October 2000 as a $20 million joint venture between the University of Melbourne (UM) and the University of Queensland (UQ). This proof of concept fund (Fund-1) operated with significant input and support from the commercialization offices of the two universities (UniQuest and Melbourne Ventures Limited), with staff ofthese organizations making up the majority of the Investment Committee and leading due diligence and management of most investment opportunities. Over 20 investments, typically of $250,000 - $500,000 were made from this fund.A new $40 million venture fund (Fund-2) ran from 2005-15, with the addition of a third leading university, the University of New South Wales, and a major private institutional investor, the Westscheme superannuation fund. The founding universities (UQ & UM) also committed further funds. Australian Super took over Westscheme's essets and commitments in July 2011.With the start of Fund-2, an independent management team was established, consisting of the CEO and three Investment Managers; one at each university catchment. The Investment Committee was restructured, with dedicated committees established for biotechnology or other technologies. The nominal investment limit was increased to $2.5 million to allow participation in follow-on funding rounds so as to preserve Uniseed's equity position.On 1 November 2015, Uniseed started its third and largest fund (Fund-3) with the addition of the University of Sydney and the CSIRO to the Universities of Queensland, Melbourne and NSW. This followed three high profile exits in the preceding 14 months (Fibrotech; Spinifex & Hatchtech). Each of the five partners committed $10 million over 10 years to the new fund (total fund $50 million).Uniseed’s partner research organisations spent nearly $4 billion on research, making up over 40% of the total research spend at 67 research organisations in Australia. Together, these organisations accounted for nearly 500 invention disclosures (34% of total) and 500 new registered IP rights filed (45% of total) over the same period(2013 National Survey of Research Commercialisation). Unlike private venture capital funds, Uniseed is dedicated to the needs of its research partners, and committed to servicing them consistently over the long term, irrespective of the short term conditions in external capital markets. It works in very close partnership with the research partner commercialisation companies and staff, providing a valuable adjunct to the capabilities these companies and staff provide. They in turn provide a best-practice commercialisation service tailored to their respective organisations. These companies are able to leverage to great effect the scale of operation and expertise of the Uniseed network.The fund is run with commercial discipline, ensuring independence and financial rigor in its investment decision-making processes. Success is measured by a balance of return on investment (including the flow of funds for research to further the commercialisation of intellectual property generated within the research partner catchments), the establishment of viable start-up companies, the generation of research income for research partners and the improvement of partner commercialisation processes.
Show more
Investment focus
  • Biotechnology, Manufacturing, Health Care
  • Series A, Seed, Series B
  • Australia, United States, United Kingdom
Portfolio highlights
  • Diraq — Diraq uses spins in silicon quantum dots as qubits. Diraq's qubits are compatible with existing CMOS processes and can fit billions of qubits on a single chip. To transform our world, quantum computers need billions of qubits and Diraq has the IP, the team and the plan to get there.
  • Celosia Therapeutics — The Celosia Therapeutics approach is the result of advances in gene therapies and a better understanding of the molecular pathways that contribute to neurodegenerative diseases.
  • Kinoxis Therapeutics — Developing novel therapeutics for social dysfunction and substance use disorders.
Uniseed Ventures VC Fund · Brisbane, Queensland, Australia
Uniseed was established in October 2000 as a $20 million joint venture between the University of Melbourne (UM) and the University of Queensland (UQ). This proof of concept fund (Fund-1) operated with significant input and support from the commercialization offices of the two universities (UniQuest and Melbourne Ventures Limited), with staff ofthese organizations making up the majority of the Investment Committee and leading due diligence and management of most investment opportunities. Over 20 investments, typically of $250,000 - $500,000 were made from this fund.A new $40 million venture fund (Fund-2) ran from 2005-15, with the addition of a third leading university, the University of New South Wales, and a major private institutional investor, the Westscheme superannuation fund. The founding universities (UQ & UM) also committed further funds. Australian Super took over Westscheme's essets and commitments in July 2011.With the start of Fund-2, an independent management team was established, consisting of the CEO and three Investment Managers; one at each university catchment. The Investment Committee was restructured, with dedicated committees established for biotechnology or other technologies. The nominal investment limit was increased to $2.5 million to allow participation in follow-on funding rounds so as to preserve Uniseed's equity position.On 1 November 2015, Uniseed started its third and largest fund (Fund-3) with the addition of the University of Sydney and the CSIRO to the Universities of Queensland, Melbourne and NSW. This followed three high profile exits in the preceding 14 months (Fibrotech; Spinifex & Hatchtech). Each of the five partners committed $10 million over 10 years to the new fund (total fund $50 million).Uniseed’s partner research organisations spent nearly $4 billion on research, making up over 40% of the total research spend at 67 research organisations in Australia. Together, these organisations accounted for nearly 500 invention disclosures (34% of total) and 500 new registered IP rights filed (45% of total) over the same period(2013 National Survey of Research Commercialisation). Unlike private venture capital funds, Uniseed is dedicated to the needs of its research partners, and committed to servicing them consistently over the long term, irrespective of the short term conditions in external capital markets. It works in very close partnership with the research partner commercialisation companies and staff, providing a valuable adjunct to the capabilities these companies and staff provide. They in turn provide a best-practice commercialisation service tailored to their respective organisations. These companies are able to leverage to great effect the scale of operation and expertise of the Uniseed network.The fund is run with commercial discipline, ensuring independence and financial rigor in its investment decision-making processes. Success is measured by a balance of return on investment (including the flow of funds for research to further the commercialisation of intellectual property generated within the research partner catchments), the establishment of viable start-up companies, the generation of research income for research partners and the improvement of partner commercialisation processes.
Show more
Investment focus
  • Biotechnology, Manufacturing, Health Care
  • Series A, Seed, Funding Round
  • Australia, United States, United Kingdom
Portfolio highlights
  • BioScout — Welcome to BioScout, your partner in revolutionizing the agriculture industry with cutting-edge automated disease detection technology for crop growers and viticulture.
  • Ferronova — Ferronova is a medical device company that offers imaging and surgery products.
  • Morse Micro — Morse Micro is a fast-growing wireless integrated circuit solutions company that is reinventing Wi-Fi for the Internet of Things (IoT). The company was founded by Wi-Fi pioneers and innovators, Michael De Nil and Andrew Terry, joined by the original Wi-Fi inventor Prof. Neil Weste and wireless industry veterans, whose teams designed Wi-Fi chipsinto billions of smartphones. Headquartered in Australia with offices in China and the U.S., Morse Micro’s strong and diverse system team, portfolio of IP and patents, enables Wi-Fi HaLow connectivity across the complete IoT ecosystem, from surveillance systems and access control to industrial automation and mobile devices, allowing connected devices to reach farther. www.morsemicro.com
Stoic VC VC Fund · Sydney, New South Wales, Australia
Stoic VC is an early-stage venture fund backing founders at the forefront of University Innovation. We partner with Uniseed to accelerate the commercialisation of university research across the ANZ.
Show more
Investment focus
  • Biotechnology, Medical, Health Care
  • Seed, Funding Round, Series A
  • Australia, United States, United Kingdom
Portfolio highlights
  • BioScout — Welcome to BioScout, your partner in revolutionizing the agriculture industry with cutting-edge automated disease detection technology for crop growers and viticulture.
  • Lenexa Medical — Lenexa Medical is driving towards better healthcare solutions for patients in hospital and aged-care by preventing pressure injuries and empowering clinicans.
  • Kinoxis Therapeutics — Developing novel therapeutics for social dysfunction and substance use disorders.
Main Sequence Ventures VC Fund · Sydney, New South Wales, Australia · 10 investments in the past 12 months
We work with inventors who are building something hard from their unique expertise in science. These inventors are building the industries that will thrive for the decades to come. We have a unique working model to accelerate a company's pathway to scale.
Show more
Investment focus
  • Software, Artificial Intelligence, Information Technology
  • Seed, Series A, Series B
  • Australia, United States, Philippines
Portfolio highlights
  • Levur — Levur produces oils inspired by nature, without the environmental impact. Our vision is a future where reliance on unsustainable plant and animal oils like Palm Oil is drastically reduced, mitigating environmental impacts. We are collaborating with large consumer goods manufacturers to make this a
  • Arkeus — Arkeus is a leader in the fusion of optics and autonomy. Our wide area autonomous optical systems are deployed to conduct Search, Intelligence, Surveillance and Reconnaissance in a range of operating environments.
  • QuintessenceLabs — Quantum cyberattacks can break current encryption in minutes! Get protected with QuintessenceLabs quantum key distribution, generation, and management.
Giant Leap Fund VC Fund · Melbourne, Victoria, Australia
Giant Leap is Australia's first venture capital fund to be 100% dedicated to investing in exceptional, rapidly scalable impact businesses.
Show more
Investment focus
  • Health Care, Information Technology, Software
  • Seed, Series A, Funding Round
  • Australia, United States, United Kingdom
Portfolio highlights
  • Mindset Health — Mindset Health is a digital therapeutics company that helps people manage chronic health issues like irritable bowel syndrome and anxiety with app-based hypnotherapy.
  • Great Wrap — The only Australian made and owned compostable cling wrap
  • Conserving Beauty — Acne Care Reimagined. Skincare formulated for for acne-prone and sensitive skin. Clinically tested and shown to cause no dermal irritation or sensitization. Australian and STEM Female Founded.
Icehouse Ventures VC Fund · Auckland, Auckland, New Zealand · 10 investments in the past 12 months
Icehouse Ventures is an early-stage venture capital firm. We exist to back the world's bravest Kiwi founders, launching global companies from New Zealand.
Show more
Investment focus
  • Software, SaaS, Information Technology
  • Seed, Series A, Funding Round
  • New Zealand, United States, United Kingdom
Portfolio highlights
  • Halter — Halter creates GPS enabled, solar powered collars for cows. The collar hardware allows farmers to use simple tablet app software to remotely set geographic boundaries for cattle, virtual fences. Farmers use Halter's system to avoid physically herding cows, maximizing farmer time and productivity.
  • Marama Labs — Marama Labs provides an integrated chemical analysis platform that empowers customers to optimize their production processes and match their products and brands to customer needs, with ease.
  • Watchful — Watchful operates as an AI security company.
Right Click Capital VC Fund · Sydney, New South Wales, Australia
Right Click Capital - Australian Venture Capital Firm
Show more
Investment focus
  • Software, SaaS, Artificial Intelligence
  • Seed, Series A, Funding Round
  • Australia, Singapore, United States
Portfolio highlights
  • black.ai — Build smarter spaces with Black.ai
  • Tability — Automate the boring parts of OKRs to cut the waste and spend more time doing what really matters.
  • Nomad Atomics — At Nomad Atomics, we develop innovative quantum sensors to solve outstanding problems in mining, underground resources and navigation
IP Group VC Fund · London, England, United Kingdom · 7 investments in the past 12 months
IP Group's core business is the creation of value for its shareholders and partners through the commercialisation of intellectual property originating from research intensive institutions. Their strength lies in managing this process from finding suitable intellectual property to commercialise to either helping develop businesses and createvalue out of them, or identifying and establishing appropriate commercial partnerships to do so. IP Group's extensive expertise in this area combined with its inside knowledge of both industry and finance have enabled the group to create a formidable track record of consistently delivering excellent results for their companies, for their partners and for their shareholders.
Show more
Investment focus
  • Health Care, Biotechnology, Information Technology
  • Seed, Series A, Funding Round
  • United Kingdom, United States, Australia
Portfolio highlights
  • Lumai — Lumai delivers fully optical computing for a quicker, smarter and more sustainable world. Lumai power the revolution of fully optical computing by working at the nexus of photonics and machine learning.
  • Alimetry — Alimetry is a health technology startup based in Auckland, New Zealand, developing breakthrough solutions for diagnosing disorders of gastrointestinal (GI) function.
  • Diffblue — Diffblue Cover uses next generation autonomous AI to automate unit testing so that Java development teams can build better applications faster
Transition Level Investments VC Fund · Brisbane, Queensland, Australia
Founded by Steve Baxter, Transition Level Investments provides equity capital and operational expertise across Seed and Series A rounds to Australian companies. Our team focuses on a company-growth approach, adding value by assisting founders to build their expertise, expand their team, build product, scale locally and globally to position for asuccessful exit. We have a track record of identifying investment opportunities in the Australian market and helping enable global growth.
Show more
Investment focus
  • SaaS, Artificial Intelligence, Software
  • Seed, Pre-Seed, Series A
  • Australia, United States
Portfolio highlights
  • Kapiche — Top-rated customer feedback analytics platform. Instant insights. No setup or coding. Kapiche ingests & analyzes feedback in minutes for real customer insights.
  • FloodMapp — Enhance operational efficiency, lead time, situational awareness and decision making using FloodMapp rapid flood mapping software.
  • Chipper Cash — Join over 5 million people securely sending and receiving money with Chipper Cash. Great app to send and receive money across a number of countries, highly recommended as a money transfer alternative.
Regal Funds Management VC Fund · Sydney, New South Wales, Australia
Regal Funds Management was founded in 2004 by Andrew and Philip King. Regal utilises a long/short investment strategy and performs investment management and investment advisory services to a number of Australian Unit Trusts and Cayman Island Companies.
Show more
Investment focus
  • Software, Financial Services, FinTech
  • Funding Round, Series B, Convertible Note
  • Australia, United States, United Kingdom
Portfolio highlights
  • Nykaa — Nykaa is an e-Commerce platform for different beauty and wellness products for men and women. They also offer comprehensive content including product reviews, beauty how-to videos, articles by experts, and an e-beauty magazine. Their helpline helps to choose products and services best suited for customer's needs. Nykaa's products areauthentic sourced directly from brands and provide a delivery experience.Nykaa was founded in 2012 by Falguni Nayar and is headquartered in Mumbai, Maharashtra, India.
  • Send Payments — SendFX provides cross-border payment and remittance services to individuals and SMEs.
  • Send Payments — Send is a fast-growing fintech delivering embedded finance solutions to well-known brands.
Pacific Channel VC Fund · Auckland, Auckland, New Zealand · 4 investments in the past 12 months
Investing in great people solving hard problems to create a better future.
Show more
Investment focus
  • Medical Device, Medical, Information Technology
  • Seed, Series A
  • New Zealand, Australia
Portfolio highlights
  • PHNXX — PHNXX provides containerised clean and reliable energy solutions for business operations.
  • Conry Tech — Conry Tech is a climate tech company, reinventing air-conditioning to decarbonise and improve comfort, founded by renowned HVAC industry revolutionising experts.
  • Green Gravity — Green Gravity is an electric power generation company that enables renewable energy transition using energy storage technology.
Matū Group VC Fund · Auckland, Auckland, New Zealand
Investing in scalable science and deep tech start-ups in Aotearoa NZ. We operate venture capital funds that invest in science and deep tech through a hands-on, active approach.
Show more
Investment focus
  • Biotechnology, Robotics, Nanotechnology
  • Seed
  • New Zealand, United States
Portfolio highlights
  • Ligar — Providing molecular filtration solutions to companies in the food, beverage, health, therapeutics, flavour and aroma industries. Our unique MIP and Polymer technology enables companies to improve their products and operational processes by extracting, reducing or concentrating flavours or compounds.
  • Alimetry — Alimetry is a health technology startup based in Auckland, New Zealand, developing breakthrough solutions for diagnosing disorders of gastrointestinal (GI) function.
  • PowerON — Dielectric Elastomers for Soft Robotics
Hostplus VC Fund · Melbourne, Victoria, Australia · 8 investments in the past 12 months
Join our leading Australian superannuation fund, committed to putting our members first, with a low admin fee and strong returns. Become a member today!
Show more
Investment focus
  • Software, Biotechnology, Renewable Energy
  • Series A, Series B, Series C
  • Australia, United Kingdom, United States
Portfolio highlights
  • Airwallex — Grow your business faster with Airwallex - global business accounts, high speed transfers, multi-currency cards, online payments, embedded finance, and more.
  • Brainomix — Since launching as a spin-out from the University of Oxford in 2010, Brainomix has developed award-winning, AI-powered imaging biomarkers, assisting physicians across the world to make better life-saving decisions. Brainomix seminal product, e-Stroke is a collection of tools that use state-of-the-art AI algorithms to support doctors by providingreal-time interpretation of brain scans to help guide treatment and transfer decisions for stroke patients, allowing more patients to get the right treatment, in the right place, at the right time.
  • Cardiac Dimensions — Cardiac Dimensions, Inc. is a medical device company developing novel interventional tools for the treatment of heart failure and the related condition of mitral valve regurgitation. Our product, the Carillon® Mitral Contour System®, is a groundbreaking, non-surgical device developed to treat functional mitral valve regurgitation. Our system uses acatheter based approach to reshape the mitral valve and reduce mitral regurgitation.
Australian Medical Angels VC Fund
Medical Angels is the premier medical and health-specific angel investment syndicate, comprised of over 1,000 clinicians from across Australia.
Show more
Investment focus
  • Events, Sports, Cycling
  • Pre-Seed
  • Hong Kong
Portfolio highlights
  • Sineva — Sineva is a medical device manufacturing firm that makes ultrasonography simulators.
  • VueMotion Labs — Optimize athletic performance with VueMotion's AI-driven movement analysis. Accessible, affordable, and trusted by pro teams worldwide. Start testing today!
  • Neogenix Biosciences — NeoGenix Fertility: Selecting sperm for life through microfluidics and AI
Tyson & Blake VC Fund · London, England, United Kingdom
Tyson & Blake We identify growth companies with unique approaches and innovative technologies that have the potential to make a profound contribution to society.We develop inspiring businesses that share our goals and our values.We create a positive impact and long-term value for our investors, the companies we invest in and the communitieswe live in.
Show more
Investment focus
  • Medical, Facial Recognition, Artificial Intelligence
  • Seed, Funding Round
  • Australia
Portfolio highlights
  • Strong Room AI — Software that enables high-strength care through streamlined workflows, continuous analytics, surfaced insights and safeguarded data.
Carthona Capital VC Fund · Sydney, New South Wales, Australia · 9 investments in the past 12 months
Carthona Capital is a hands-on, proactive, and thematic venture capital investor based in Sydney, Australia that invests globally.
Show more
Investment focus
  • Software, Financial Services, FinTech
  • Seed, Series A, Series B
  • Australia, United States, United Kingdom
Portfolio highlights
  • Qlarifi — Consumer lending decisions transformed with real time, comprehensive data.
  • Safewill — Safewill is Australia's leading online Will writing platform. With thousands of users, Safewill makes it easy and affordable to write your own legally binding will
  • Ajust — Ajust makes it easy to resolve customer complaints with banks, telcos and energy companies. It's fast, fair and free for consumers.
Horizons Ventures VC Fund · Hong Kong, Hong Kong Island, Hong Kong · 4 investments in the past 12 months
Investing in the deep science and technology that can propel humanity towards a radically better future.
Show more
Investment focus
  • Biotechnology, Artificial Intelligence, Software
  • Series A, Series B, Seed
  • United States, United Kingdom, Canada
Portfolio highlights
  • Notpla — We are a combination of designers and chemists, engineers and entrepreneurs. We’re hard to define because what we’re doing hasn’t been done before. We create advanced packaging solutions that disappear, naturally.
  • Owlstone Medical — Owlstone Medical has developed a breathalyzer for disease. With a focus on non-invasive diagnostics for cancer, inflammatory disease, and infectious disease, the company aims to save 100,000 lives and $1.5B in healthcare costs.The company’s Breath Biopsy® platform has introduced a new diagnostic modality making it possible to discover novelnon-invasive biomarkers in breath using a platform with the potential to transition to point-of-care. The award-winning ReCIVA Breath Sampler ensures a reliable collection of breath samples. The volatile organic compounds (VOCs) present in the breath are analyzed using proven microchip chemical sensor technology (FAIMS) to detect biomarkers of disease.The Breath Biopsy platform can be used in clinical diagnostics and precision medicine with applications in cancer and a wide range of other medical conditions. Highly sensitive and selective, these tests allow for early diagnosis when treatments are more effective and more lives can be saved.Owlstone Medical is currently developing tests for lung and colorectal cancer, two of the most common cancer killers worldwide, and for asthma stratification by the therapeutic response. The company also Breath Biopsy products and services to academic, clinical, and pharma partners who want to develop breath-based diagnostics for their own applications.
  • Fleet Space Technologies — Fleet is an agile, next generation connectivity company. Our mission is to Connect Everything using cutting-edge communications and space technologies to maximise the resource efficiency of human civilisation and enable the next industrial revolution with our free, ubiquitous connectivity platform.
Sydney Angels VC Fund · Sydney, New South Wales, Australia
Sydney Angels is a not-for-profit angel investment membership organisation. Since our establishment in 2008, they have stayed true to our mission of supporting the early-stage ecosystem by running processes and events that connect our investing members with promising early-stage companiesThey believe that encouraging smart investment in startupcompanies will benefit both our members’ portfolios and Australia’s emergent innovation economy.They see this as the ultimate win-win situation. Sydney Angels is led by an elected committee of ten volunteers who meet weekly. It is supported by an operations manager and alliance partners.
Show more
Investment focus
  • Software, Health Care, SaaS
  • Seed, Angel, Series A
  • Australia, United States
Portfolio highlights
  • Okkular — Okkular is an AI based fashion tech startup.
  • Apollo Secure — Cyber for Humans - an automated cybersecurity platform for startups and small businesses to improve security maturity and simplify security compliance.
  • Mary Technology — Generate detailed chronologies from documents in minutes with Mary Technology. Achieve 90%+ time reduction and ensure 99%+ accuracy. Try for free.
Clinton Capital Partners VC Fund · Sydney, New South Wales, Australia
Clinton Capital Partners is a VC advisory business that specialises in raising capital and growing shareholder returns, for early stage technology companies and their investors. In addition, we invest our own funds to align company, investor and advisor. We have completed >70 successful transactions, and crystallised 14 liquidity events.Clinton Capital Partners has a long and established track record of growing companies, raising capital, conducting mergers, and creating liquidity events. When raising capital, we feel early-stage companies underestimate the time involved, the distraction to the underlying business, and the importance of identifying the “right culturally aligned” investors for their journey.
Show more
Investment focus
  • Software, E-Commerce, Health Care
  • Seed, Series A, Funding Round
  • Australia, United States
Portfolio highlights
  • OpusXenta — Byond is comprehensive business management software for cemeteries & crematoria, streamlining operations with mapping, record-keeping, sales management and more.
  • PaidRight — Know your payroll compliance. Monitor variances in your payroll, get insights and visibility into your own payroll systems and processes so your employees are paid right.
  • FLK It Over — Sign documents online easily with FLK it over. Get started with our electronic signature software in just 2 minutes with our 14-day free trial. Try it now!
Enterprise Angels VC Fund · Tauranga, Gisborne, New Zealand
Connecting startup business owners with angel investors to raise capital . Access a network of expertise and investment opportunities.
Show more
Investment focus
  • Software, Information Technology, Health Care
  • Funding Round, Seed, Angel
  • New Zealand, United States, United Kingdom
Portfolio highlights
  • Emerge — Emerge is a financial management tool for businesses. It is a digital-only banking option designed to help Kiwi businesses operate more quickly, economically, and efficiently.
  • Yabble — Yabble provides a platform that uses machine learning and natural language processing to help brands connect with more than 62 million consumers globally, and collect data in real-time. Using the solution, clients can build their own surveys and manage their own customer research communities.
  • Zenno Astronautics — Zenno Astronautics hardware and software products ensure satellite missions are effectively managed, guaranteeing maximum economic returns and responsible use of space.
Fund WA VC Fund · Perth, Western Australia, Australia
FundWA is a Western Australian venture capital fund that invests in technology-enabled innovative businesses in Western Australia.
Show more
Investment focus
  • Medical, Health Care, Medical Device
  • Seed, Series A
  • Australia
Portfolio highlights
  • Hola Health — 24 hour online doctors & GP consults via telehealth appointments in 15 minutes. Get instant scripts online, medical certificate online anywhere in Australia.
  • VitalTrace — VitalTrace is a medical device company helps mothers and children during labour and delivery by innovating new monitoring devices.
EVP VC Fund · Sydney, New South Wales, Australia · 3 investments in the past 12 months
EVP is an early stage venture capital firm based in Sydney Australia with c. $300M FUM across four fund vintages.Our most recent fund was launched in December 2022 and is a $100M fund. The fund targets early Series-A investments initially with cheque sizes in the range of $0.5 – $5.0 million. Our funds invest in software, are sector agnosticand have a focus on Australian based B2B SaaS companies.Over the years, we’ve backed brilliant founders building global software companies like SiteMinder, Deputy, Ignition and Shippit. We make high conviction investments, underpinned by ambition, pragmatism and a deep understanding of the software journey.
Show more
Investment focus
  • Software, SaaS, Information Technology
  • Series A, Seed, Funding Round
  • Australia, New Zealand, United States
Portfolio highlights
  • Modii — Modii is a leading provider of smart parking solutions, dedicated to transforming the way parking and mobility are managed and experienced through a unified platform of digital infrastructure, data integration, and parking intelligence. By integrating cutting-edge technology with user-friendly platforms, Modii helps institutions, organizations, andurban areas optimize their parking operations, improve efficiency, and enhance user satisfaction by enabling thoughtful parking planning through data-driven insights. For more information about Modii visit modii.co.
  • splose — splose isn’t just practice management software. It's your ally in handling the ins-and-outs of running a practice and a savvy tool for growth. At splose, we are dedicated to continuously improving and embracing the power of AI and automation to give healthcare professionals like you more time to focus on what matters most.
  • InvestorHub — We provide comprehensive access to listed capital raises for institutional, family office and high net worth investors.
Starfish Ventures VC Fund · Melbourne, Victoria, Australia
Starfish Ventures is an Australian venture capital firm focused on information technology, life sciences, and clean technology companies.
Show more
Investment focus
  • Software, Enterprise Software, Information Technology
  • Series A, Series B, Funding Round
  • United States, Australia, Philippines
Portfolio highlights
  • Aktana — Build stronger relationships with HCPs using Aktana's artificial intelligence (AI) platform for life sciences to optimize omnichannel engagement.
  • DesignCrowd — Crowdsourced logo, freelance graphic and web design at DesignCrowd. 1,293,506 freelance designers compete to create amazing designs for your business. Start Today!
  • Marani — Marani helps maternity providers quickly identify and manage maternal and fetal risk as well as empowering moms to have healthier pregnancies.
Purpose Ventures VC Fund · Perth, Western Australia, Australia
Purpose Ventures is a Venture Capital Fund in Perth Western Australia backing the next generation of entrepreneurs and innovators.
Show more
Investment focus
  • EdTech, Medical, Education
  • Seed
  • Australia
Portfolio highlights
  • PlanCare — Plan Care is a technology platform that helps participants via dedicated plan managers by providing guidance and responding to queries.
  • My Mirror — Find the right online psychologist in Australia, tailored to your needs and schedule. Start online therapy today with no wait times. Book now, pay later
  • Andromeda Robotics — At Andromeda, our personalised robot companions are helping Australian aged care teams bring joy and connection to residents to improve wellbeing.
Jolimont Global Mining Systems VC Fund · Denver, Colorado, United States
Resource Capital Funds is a mining-focused alternative investments firm that partners with companies to build strong, successful, and sustainable businesses.
Show more
Investment focus
  • Construction, Software, SaaS
  • Funding Round, Seed, Convertible Note
  • Australia, United States
Portfolio highlights
  • SciAps — SciAps specializes in portable analytical instruments with the power to measure any element. Our industry-leading X-ray fluorescence (XRF) and laser-based (LIBS) analyzers are at work across every major industry.
  • APE Mobile — APE Mobile develops a paperless site application for contractors in Australia. Its site application comprises features, such as operational forms, safety forms, project management, actions and defects, drawings and documents, and redline markup. David Hayward and Matthew Edwards founded APE Mobile in January 2, 2009. Its headquarters is inLeederville in Australia.
  • QuickSafety — Now you can quickly and easily complete Certificate of Compliance in Sydney, Melbourne, Brisbane & New Zealand using the Quicksafety mobile app.
Blackbird Ventures VC Fund · Sydney, New South Wales, Australia · 19 investments in the past 12 months
Blackbird is a venture capital fund based in Australia and New Zealand. We invest in every type of technology from software to space, unified by the biggest of ambitions.
Show more
Investment focus
  • Software, SaaS, Artificial Intelligence
  • Seed, Series A, Pre-Seed
  • Australia, United States, New Zealand
Portfolio highlights
  • Ravio — Ravio allows you to understand compensation in your market in real-time. Make smarter salary, equity and benefits decisions without touching a spreadsheet.
  • Halter — Halter creates GPS enabled, solar powered collars for cows. The collar hardware allows farmers to use simple tablet app software to remotely set geographic boundaries for cattle, virtual fences. Farmers use Halter's system to avoid physically herding cows, maximizing farmer time and productivity.
  • Blinq — Blinq makes it easy to share your contact details via QR code scanning on the mobile app.
Folklore Ventures VC Fund · Sydney, New South Wales, Australia
Folklore is a team of investors, founders, and builders committed to supporting Australian and New Zealand tech founders. We are a first cheque to forever investment firm, and we believe in the power of founder vision and the potential of teams, right from the start.
Show more
Investment focus
  • Software, Apps, Information Technology
  • Seed, Series A, Funding Round
  • Australia, United States, New Zealand
Portfolio highlights
  • Kry10 — Kry10 is a safe operating system for SDMs.It makes the transition to an intelligent, cloud-connected, and adaptively driven future possible for automobiles, electricity grids, satellites, and medical equipment.
  • SimConverse — SimConverse is a simulation platform that uses generative AI to play the role of any patient, colleague or casualty.
  • Forever Network — Forever Network is a social-first sports media company. Our keystone brand, Basketball Forever, is the worlds largest independent sports media channel.
Sante Ventures VC Fund · Austin, Texas, United States · 7 investments in the past 12 months
Privately Held Companies
Show more
Investment focus
  • Health Care, Medical, Biotechnology
  • Series A, Series B, Series C
  • United States, Canada, Australia
Portfolio highlights
  • Graici — Meet Graici, Adaptive Engagement Technology delivering at the speed of need to power positive outcomes for individuals and institutions.
  • Ten Bay Bio — Ten Bay Bio is a biotechnology company that offers biological therapies for treatment of complex diseases in immunology.
  • Solu Therapeutics — Solu Therapeutics is a precision-medicine-focused company developing therapeutics to eliminate disease-driving cells.
Kurt Alexander Angel · Brisbane, Queensland, Australia
Kurt Alexander
Show more
Investment focus
  • Mining, Retail, Medical
  • Seed, Funding Round
  • Australia
Portfolio highlights
  • QuickSafety — Now you can quickly and easily complete Certificate of Compliance in Sydney, Melbourne, Brisbane & New Zealand using the Quicksafety mobile app.
Stephen Baxter Angel · Brisbane, Queensland, Australia
Stephen Baxter - Founder @ River City Labs
Show more
Investment focus
  • Health Care, SaaS, Artificial Intelligence
  • Seed, Angel, Pre-Seed
  • Australia, United States
Portfolio highlights
  • DoseMe — Quick, simple & easy dosing calculator. With DoseMeRx in your EHR, save time & predict the optimal dose of medications with just one blood sample.
  • Kapiche — Top-rated customer feedback analytics platform. Instant insights. No setup or coding. Kapiche ingests & analyzes feedback in minutes for real customer insights.
  • OrionVM Wholesale Cloud Superstructure — OrionVM is a Wholesale Cloud Infrastructure-as-a-Service (IaaS) company that has developed a revolutionary technology suite (virtual storage, compute, orchestration and virtual networking) to enable the delivery of high performing, highly reliable cloud solutions at market leading price-to-performance ratios. Groundbreaking engineering supportsPublic, Hybrid and Private Cloud deployments and offers an agile system for internal consumption or resale. OrionVM’s Wholesale Cloud Platform provides the best margins, superior performance, and increased technical reliability for resellers and wholesalers of cloud services. OrionVM’s head office is in Sydney, Australia, with U.S. offices also in the San Francisco Bay Area.
Mass Medical Angels VC Fund · Boston, Massachusetts, United States
Mass Medical Angels (MA2) was founded to answer the need for a dedicated life-science centric angel group in New England. The Boston area is a world-leading supercluster for medical innovation, but all early-stage companies in the field have tremendous difficulty with first round funding. Their goal is to provide money and mentoring to the lifescience community to achieve superior returns for their group, and more clinical innovation for the community.
Show more
Investment focus
  • Health Care, Biotechnology, Medical Device
  • Series A, Series B, Seed
  • United States, Israel, Australia
Portfolio highlights
  • Coviu — Video chat, secure messaging, appointment booking, prescription delivery, in-app assessments, in-call tools. Made for practitioners, clinics and hospitals.
  • Capillary Biomedical — Make diabetes management easier with insulin pumps and other innovative products and services from Tandem Diabetes Care.
  • Astrocyte Pharmaceuticals — Astrocyte Pharmaceuticals Inc. is a privately held drug development company dedicated to accelerating the recovery and well-being of brain injury patients. The company is committed to proving the neuroprotective benefits of selective astrocyte activation, and advancing breakthrough therapeutic agents for treating brain injury resulting from stroke,TBI, concussion, and neurodegenerative disorders such as Alzheimer’s disease.
HESTA VC Fund · Melbourne, Victoria, Australia · 2 investments in the past 12 months
HESTA Super Fund is the Australian industry superannuation fund for people working in health and community services. Become a member today.
Show more
Investment focus
  • Solar, Semiconductor, Information Technology
  • Series A, Series B, Private Equity
  • Australia, United States
Portfolio highlights
  • Heidi Health — Heidi Health is modernizing primary care with AI-powered technologies to improve care's quality and accessibility. its creators and engineers is to completely eradicate missed and sluggish diagnoses worldwide. They are committed to bridging the gap between the level of care that patients desire and the level of care that doctors can delivergiven their budget constraints. To create a platform where patients can quickly and easily get the treatment they require and to give every clinician the resources they need to deliver care that is secure, efficient,
  • SafetyCulture — SafetyCulture is the operational heartbeat of working teams around the world. Its mobile-first operations platform leverages the power of human observation to identify issues and opportunities for businesses to improve everyday. More than 28,000 organisations use its flagship products, iAuditor and EdApp, to perform checks, train staff, reportissues, automate tasks and communicate fluidly. SafetyCulture powers over 600 million checks per year, approximately 50,000 lessons per day and millions of corrective actions, giving leaders visibility and workers a voice, in driving safety, quality and efficiency improvements.
  • Generate Capital — Generate Capital is a finance company that builds, owns, and operates sustainable infrastructure to deliver affordable and reliable resource solutions. The company operates and finances assets in energy, mobility, and water resources.
New Zealand Venture Investment Fund VC Fund · Auckland, Auckland, New Zealand
Your guide to finding and using government services.
Show more
Investment focus
  • Software, Biotechnology, SaaS
  • Seed, Series A, Angel
  • New Zealand, United States, Japan
Portfolio highlights
  • Insite AI — We create predictability for consumer brands in the unpredictable world of retail. Game-changing technology that attacks consumer brands' hardest problems.
  • Invert Robotics — Invert Robotics develops robotic NDT inspection technologies for the maintenance of industrial equipment in the food and beverage, pharmaceutical, and oil and gas industries. Invert Robotics highly skilled team of engineers have developed a world leading modular inspection platform suitable for use across a range of industries and applications.
  • Surgical Design Studios — The Insides Company is the leading provider of chyme reinfusion solutions for intestinal failure
AustralianSuper VC Fund · Melbourne, Victoria, Australia
AustralianSuper is run only to benefit members, offering low fees and strong long-term investment returns.
Show more
Investment focus
  • Information Technology, Hotel, Solar
  • Funding Round, Series A, Series C
  • Australia, United States, United Kingdom
Portfolio highlights
  • Peel Ports — Peel Ports is a unique network of strategically situated ports, terminals, hubs, shipping lines, and state-of-the-art services.
  • SiteMinder — SiteMinder is the world’s leading open hotel commerce platform, ranked among technology pioneers for opening up every hotel’s access to online commerce. It’s this central role that has earned SiteMinder the trust of tens of thousands of hotels, across 150 countries, to sell, market, manage and grow their business. The global company, headquarteredin Sydney with offices in Bangkok, Berlin, Dallas, Galway, London and Manila, generated more than 100 million reservations worth over US$35 billion in revenue for hotels in the last year prior to the start of the pandemic.
  • Generate Capital — Generate Capital is a finance company that builds, owns, and operates sustainable infrastructure to deliver affordable and reliable resource solutions. The company operates and finances assets in energy, mobility, and water resources.
Melbourne Angels VC Fund · Melbourne, Victoria, Australia
Melbourne Angels was formed in Melbourne, Australia in early 2007. Melbourne Angels is the leading group of private investors in Victoria who actively invest in early stage and growth technology companies.The group has a strong and experienced core of members that generate deal flow, are experienced in evaluation of business propositions and actas mentors for the other members and the entrepreneurs. The members vary in age, gender, ethnicity, profession and type of experience. All members have experience of success at being entrepreneurial.This award winning group is consistently one of the most active startup investors in the country.
Show more
Investment focus
  • Biotechnology, Information Technology, Manufacturing
  • Angel, Seed, Funding Round
  • Australia, United States, New Zealand
Portfolio highlights
  • Insite AI — We create predictability for consumer brands in the unpredictable world of retail. Game-changing technology that attacks consumer brands' hardest problems.
  • Apop Imaging — Apop Imaging develops and commercialises novel imaging, diagnostic and therapeutic tools to improve patient outcomes based on our proprietary calcitonin receptor antibody technology.
  • Alkira Software — Deliver interactive content and answer customer queries at scale using conversational AI. TalkVia offers quick and easy NO CODE voice and chat solutions for Amazon Alexa, Google Assistant, Siri and web based chatbots.
GD1 VC Fund · Auckland, Auckland, New Zealand · 4 investments in the past 12 months
GD1 is a Venture Capital firm that invests with high conviction in exciting technology companies originating from New Zealand. Our team is passionate about creating and growing global businesses, and our goal is to transform NZ made into the next generation of globally disruptive tech solutions.
Show more
Investment focus
  • Software, SaaS, Artificial Intelligence
  • Seed, Series A, Series B
  • New Zealand, United States, China
Portfolio highlights
  • Rilla — Demonstrating 90% reduction in cost-to-serve for live-streaming, Rilla is rewiring the content economy, directing the value generated back to creators and their communities.By leveraging audience bandwidth and rewarding them with ownership in the network, the savings are equivalent to a free month subscription every year for a moderate level ofviewership.Founded by the technical founders behind Altered State Machine, acquired for 214m. Together for 5+ ventures, collectively raising 130m+ and valued at 1b+.
  • NextWork — Building the best online learning experience to switch careers and upskill. Join the waitlist today, we are waiting for you!
  • Type One Energy — At Type One Energy, we are mission-driven to provide sustainable, affordable fusion power to the world over the coming decade.
Watermark Funds Management VC Fund · Sydney, New South Wales, Australia
Watermark Funds Management. A specialist long/short investor offering attractive returns while hedging share market risks.
Show more
Investment focus
  • Medical, Software, Health Care
  • Series A
  • Australia
Portfolio highlights
  • Artrya — We use artificial intelligence for accurate cardiac imaging and heart disease diagnoses. Learn more about Salix, our noninvasive diagnostic support solution.
Auckland UniServices VC Fund · Perth, Western Australia, Australia
At UniServices, we partner with the University of Auckland to transform ideas into real-world solutions that impact globally.
Show more
Investment focus
  • Medical, Marketing, Health Care
  • Seed, Pre-Seed
  • New Zealand
Portfolio highlights
  • eVouch — eVouch is the most powerful marketing tool we've used to build an organic community. We've experienced elevated brand trust while reaching an audience we never thought possible. Using customers to market to their friends is simply genius.
  • Kitea Health — Kitea Health creates pressure monitoring implantable medical devices.
Side Stage Ventures VC Fund · Sydney, New South Wales, Australia · 2 investments in the past 12 months
Side Stage Ventures is a founder-led seed fund backing outlier founders in Australia. We write the first cheque into the best early stage companies. Then we lean in to help the founders build & scale.
Show more
Investment focus
  • Information Technology, Content, Medical
  • Seed, Series A
  • Australia
Portfolio highlights
  • TrueState — Accelerate your AI adoption with TrueState's library of high-impact AI solutions, infinitely customisable for your unique business context.
  • Thanks — Delight your most valuable customers at the moment of checkout and start unlocking new revenue with Thanks.
  • Arca Climate Technologies, Inc. — Carbin Minerals unlock the enormous carbon dioxide removal potential of mine waste.
Investible VC Fund · Sydney, New South Wales, Australia · 9 investments in the past 12 months
Investible is an early-stage venture capital firm backing the visionaries advancing humanity through technology in Australia, New Zealand, Southeast Asia and globally.
Show more
Investment focus
  • Software, Information Technology, E-Commerce
  • Seed, Series A, Pre-Seed
  • Australia, United States, Singapore
Portfolio highlights
  • Voltavate — Voltavate is dedicated to driving innovation in battery technology to support the global transition towards sustainable energy solutions.
  • Kite Magnetics — Electric motors enabling electric aircraft of all sizes to fly further, carry more and emit less. The future of aviation is electric.
  • Quantum Brilliance — Quantum Brilliance builds room temperature quantum computers powered by synthetic diamond, enabling applications in everyday computing, including edge and massively parrellelized computing.
Hillfarrance Venture Capital VC Fund · 2 investments in the past 12 months
We exist to serve great entrepreneurs with honest advice and education, investment capital that is fair, and an open door to our international network and connections.
Show more
Investment focus
  • Animation, Information Technology, Software
  • Seed, Pre-Seed, Funding Round
  • New Zealand
Portfolio highlights
  • Yabble — Yabble provides a platform that uses machine learning and natural language processing to help brands connect with more than 62 million consumers globally, and collect data in real-time. Using the solution, clients can build their own surveys and manage their own customer research communities.
  • Space Rock Games — Space Rock Games is the developer behind Criminals Within - a cooperative-only action game set in a medieval fantasy kingdom. Sign up to receive exclusive development updates!
  • Floating Rock Studio — Floating Rock Studio
CSIRO VC Fund · Campbell, Victoria, Australia
As Australia's national science agency and innovation catalyst, we solve the greatest challenges through innovative science and technology.
Show more
Investment focus
  • Software, Agriculture, Health Care
  • Series A, Funding Round
  • Australia, United States
Portfolio highlights
  • Coviu — Video chat, secure messaging, appointment booking, prescription delivery, in-app assessments, in-call tools. Made for practitioners, clinics and hospitals.
  • FutureFeed — Established by CSIRO, FutureFeed holds global IP for the use of Asparagopsis seaweed as a livestock feed ingredient, shown to lower ruminant methane emissions by 80% or more, while producing feed efficiencies.
  • Digital Agriculture Services — SaaS for financial services. Data, imagery, software and CRM integrations decision-makers need to lend, insure, invest, sell and serve customers.
Cure Kids Ventures VC Fund · Auckland, Auckland, New Zealand
Investing in innovation for a healthy childhood Investing in innovation for a healthy childhood About Cure Kids Ventures Cure Kids Ventures is a seed and early stage investment fund that invests in the commercialisation of innovations in products and services with a potential to
Show more
Investment focus
  • Medical Device, SaaS, Medical
  • Seed, Pre-Seed, Series A
  • New Zealand
Portfolio highlights
  • Avasa — Avasa is a medical device company. It helps to improve surgical procedures by developing novel implantable devices.
  • Formus — Formus Labs develops software technologies for orthopedic planning and analysis. Our mission is to improve outcomes and efficiencies through seamless and highly scalable integration of AI and computational modelling in the orthopedic clinical workflow. Based in Auckland, New Zealand, Formus Labs draws on over 10 years of research andcommercialisation experience, with operations in New Zealand, Australia, and soon in the USA.
  • Kitea Health — Kitea Health creates pressure monitoring implantable medical devices.
New Zealand Growth Capital Partners VC Fund · 2 investments in the past 12 months
The New Zealand Growth Capital Partners (formerly New Zealand Venture Investment Fund) was established to support early-stage technology companies and to stimulate private investment into this space.
Show more
Investment focus
  • Software, SaaS, Information Technology
  • Seed, Series A, Funding Round
  • New Zealand, United States
Portfolio highlights
  • Scannable — Scannable helps Arborists, Rope Access Technicians, Riggers, and Rescuers easily manage PPE and safety equipment.
  • Avasa — Avasa is a medical device company. It helps to improve surgical procedures by developing novel implantable devices.
  • Marama Labs — Marama Labs provides an integrated chemical analysis platform that empowers customers to optimize their production processes and match their products and brands to customer needs, with ease.
Novartis Venture Fund VC Fund · Basel, Basel-Stadt, Switzerland · 9 investments in the past 12 months
Learn about the approach the Novartis Venture Fund takes to investing in innovative life science companies developing biotechnology and biopharmaceutical therapeutics that address unmet patient needs.
Show more
Investment focus
  • Biotechnology, Health Care, Therapeutics
  • Series B, Series A, Series C
  • United States, Switzerland, United Kingdom
Portfolio highlights
  • Rhygaze — RhyGaze is at the forefront of developing a novel first-in-class gene therapy aimed at improving vision in patients suffering from retinal diseases.
  • Atalanta Therapeutics — Atalanta was created to address the urgent global need for interventions to treat neurodegenerative diseases.
  • Alesta Therapeutics — Alesta Therapeutics pioneers innovative small molecule therapies for rare diseases, including hypophosphatasia and Charcot-Marie-Tooth
Tin Alley Ventures VC Fund · Carlton, Victoria, Australia · 2 investments in the past 12 months
Tin Alley Ventures collaborates with companies and researchers in the University of Melbourne's ecosystem to invest in & support world-changing businesses.
Show more
Investment focus
  • Medical, Health Care, Therapeutics
  • Pre-Seed
  • Australia
Portfolio highlights
  • Cell Bauhaus — Cell Bauhaus uses mathematical and computer modeling to understand, predict, and modify living cell behavior, aiming to expedite sustainable solutions to humanity's pressing issues.
  • Remagine Labs — Remagine Labs is revolutionizing healthcare with a bluetooth-connected, wearable electro-pharmaceutical that provide patient-centered care and consistent drug administration, giving healthcare customers peace of mind all over the world.
  • Psychae Therapeutics — Psychae Therapeutics develop innovative pharmaceutical grade DMT-based medicines and therapies aiming to transform the lives of those facing some of the most prolific and insidious mental illnesses
Novaquest Capital Management VC Fund · Raleigh, North Carolina, United States
About NovaQuest Capital provides strategic capital to life science and healthcare companies. With experience managing over $2.75 billion of investor capital across multiple asset classes, the firm provides a robust life sciences and healthcare platform focused on promoting the development and gro...
Show more
Investment focus
  • Biotechnology, Health Care, Pharmaceutical
  • Private Equity, Series A, Post-IPO Equity
  • United States, New Zealand, United Kingdom
Portfolio highlights
  • Mirna — Mirna is a veterinary diagnostics company that specializes in the development of veterinary disease testing technology.
  • Hansa Biopharma — We are dedicated to developing lifesaving and life-altering treatments that can empower patients affected by rare immunologic conditions to live longer and healthier lives.
  • Phathom Pharmaceuticals — A late clinical-stage biopharmaceutical company committed to transforming the treatment landscape for people suffering from GI diseases related to acid.
Investors by industry
Investors by country
Investors in Oceania by industry